The Ensign Group, Inc. (NASDAQ:ENSG) Director John G. Nackel sold 1,000 shares of the stock in a transaction that occurred on Friday, October 5th. The stock was sold at an average price of $38.25, for a total value of $38,250.00. Following the completion of the sale, the director now owns 78,232 shares of the company’s stock, valued at approximately $2,992,374. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

ENSG opened at $38.45 on Friday. The company has a market capitalization of $1.98 billion, a PE ratio of 32.04, a PEG ratio of 1.48 and a beta of 0.65. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.42 and a quick ratio of 1.42. The Ensign Group, Inc. has a 52 week low of $20.81 and a 52 week high of $40.64.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Thursday, August 2nd. The company reported $0.44 EPS for the quarter, beating the Zacks’ consensus estimate of $0.43 by $0.01. The company had revenue of $496.40 million during the quarter, compared to analysts’ expectations of $496.61 million. The Ensign Group had a return on equity of 15.61% and a net margin of 3.61%. The firm’s revenue for the quarter was up 10.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.23 EPS. As a group, research analysts expect that The Ensign Group, Inc. will post 1.71 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 31st. Stockholders of record on Sunday, September 30th will be paid a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date of this dividend is Thursday, September 27th. The Ensign Group’s payout ratio is presently 15.00%.

A number of research analysts have recently commented on the company. ValuEngine cut The Ensign Group from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 3rd. Cantor Fitzgerald restated a “buy” rating and issued a $42.00 target price on shares of The Ensign Group in a research note on Monday, July 30th. BidaskClub upgraded The Ensign Group from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 17th. Stifel Nicolaus set a $34.00 target price on The Ensign Group and gave the company a “hold” rating in a research note on Thursday, August 16th. Finally, Zacks Investment Research cut The Ensign Group from a “buy” rating to a “hold” rating in a research note on Wednesday, August 22nd. One equities research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $38.00.

Large investors have recently made changes to their positions in the business. Schwab Charles Investment Management Inc. raised its stake in The Ensign Group by 6.0% during the second quarter. Schwab Charles Investment Management Inc. now owns 368,522 shares of the company’s stock valued at $13,201,000 after buying an additional 20,806 shares during the last quarter. BlackRock Inc. raised its stake in The Ensign Group by 14.1% during the second quarter. BlackRock Inc. now owns 7,187,953 shares of the company’s stock valued at $257,471,000 after buying an additional 890,137 shares during the last quarter. WINTON GROUP Ltd purchased a new position in The Ensign Group during the second quarter valued at $16,497,000. UBS Group AG raised its stake in The Ensign Group by 147.8% during the first quarter. UBS Group AG now owns 38,355 shares of the company’s stock valued at $1,008,000 after buying an additional 22,875 shares during the last quarter. Finally, American Century Companies Inc. purchased a new position in The Ensign Group during the second quarter valued at $6,672,000. Institutional investors and hedge funds own 84.59% of the company’s stock.

The Ensign Group Company Profile

The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses in the United States. It operates through three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, including daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors.

Read More: How Investors Use a Balance Sheet

Insider Buying and Selling by Quarter for The Ensign Group (NASDAQ:ENSG)

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.